web-bg.eu  |  Уеб каталог  |  Уеб зона  |  Уеб линкове

13 Myths About Xarelto Lawsuit

13 Myths About Xarelto Lawsuit


  1. Описание

Подробно описание


Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical firms, which includes the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use – and failure to perform so may possibly be grounds for compensation. Our lawyers are functioning challenging to get those hurt by the drug the compensation they are entitled to.

xarelto forEven though bleeding can be a frequent complication associated with anticoagulants, it has been alleged that Xarelto is a lot more hazardous than conventional blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This means that, within the event of an emergency, patients may be at threat for irreversible bleeding troubles, such as life-threatening internal and gastrointestinal hemorrhaging.

If you or possibly a loved one suffered a serious bleeding event following taking Xarelto, you might have legal recourse. For more data, make contact with us nowadays to possess your case reviewed, free of charge of charge.

Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future healthcare bills, lost wages, discomfort and suffering and, in instances of death, funeral costs. Additionally, they may be in search of punitive damages, that are typically awarded to punish the defendant and deter other businesses from acting similarly.

Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective indicates of stopping xarelto pulmonary embolism lawsuit users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.

The makers of the drug continue to market Xarelto as a protected anticoagulant option.

Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.

Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.

Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.

xarelto forVisit this page for much more information on the alleged health risks of Xarelto.

Multidistrict Litigation Trial Dates Set

The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.